SHANGHAI, May 26, 2021 /PRNewswire/ — Luye Pharma Group announced today that its holding subsidiary, Boan Biotech, has signed an agreement with AstraZeneca China regarding the promotion rights to the anticancer drug B…
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China
Huion Kamvas RDS-160: a Creative Pen Display to Empower Your Creativity
9D NFT Raised $2.9 Million – Ready For IDO
China-Singapore Trade in Services Innovation Forum to Discuss New Paths for High-Level Opening-Up
The Luxury Collection Announces Australian Debut with the Opening of The Tasman, a Luxury Collection Hotel, Hobart on 9 December 2021
